(ACRS) Aclaris Therapeutics - Performance 7.4% in 12m
Compare ACRS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-9.05%
#63 in Group
Rel. Strength
59.59%
#3216 in Universe
Total Return 12m
7.38%
#55 in Group
Total Return 5y
-9.03%
#55 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -0.13
9th Percentile in Group
FCF Yield -16.46%
(?) Percentile in Group
12m Total Return: ACRS (7.4%) vs XLV (-4.1%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
1.26% | 181% | 420% | 58.1 | 44.4 | 0.61 | 48.6% | 9.63% |
LLY NYSE Eli Lilly |
3.47% | -2.41% | 404% | 67 | 36.6 | 1.33 | 58.2% | 18.9% |
NVS NYSE Novartis |
8.01% | 14.6% | 64.6% | 17.9 | 13.9 | 1.36 | 8.40% | 9.2% |
NOVN SW Novartis |
2.79% | 4.23% | 40.3% | 19.3 | 13.9 | 1.32 | 9.80% | 11.2% |
SOBI ST Swedish Orphan Biovitrum |
12% | 5.01% | 48.3% | 25.6 | 20.9 | 1.61 | 16.1% | 29% |
SAN PA Sanofi |
-1.52% | 2.67% | 20.4% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
IPN PA Ipsen |
1.81% | -12.6% | 57.8% | 23.3 | 9.65 | 0.69 | -6.40% | -6.33% |
SUPN NASDAQ Supernus Pharmaceuticals |
2.94% | 0.77% | 35.3% | 24.6 | 20.2 | 1.47 | -5.90% | -17% |
Performance Comparison: ACRS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ACRS
Total Return (including Dividends) | ACRS | XLV | S&P 500 |
---|---|---|---|
1 Month | 6.50% | 0.87% | 13.81% |
3 Months | -45.19% | -7.96% | -6.30% |
12 Months | 7.38% | -4.06% | 10.65% |
5 Years | -9.03% | 43.49% | 107.77% |
Trend Score (consistency of price movement) | ACRS | XLV | S&P 500 |
1 Month | 70.5% | -8.1% | 83% |
3 Months | -90.4% | -75.3% | -75.3% |
12 Months | 51.4% | -28.8% | 50.1% |
5 Years | -52.3% | 89.7% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #141 | 5.58% | -6.42% |
3 Month | #171 | -40.5% | -41.5% |
12 Month | #55 | 11.9% | -2.95% |
5 Years | #57 | -36.6% | -56.2% |
FAQs
Does ACRS Aclaris Therapeutics outperforms the market?
Yes,
over the last 12 months ACRS made 7.38%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months ACRS made -45.19%, while XLV made -7.96%.
Over the last 3 months ACRS made -45.19%, while XLV made -7.96%.
Performance Comparison ACRS vs Indeces and Sectors
ACRS vs. Indices ACRS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -6.25% | -7.31% | -45.4% | -3.27% |
US NASDAQ 100 | QQQ | -6.44% | -10.9% | -45.7% | -4.26% |
US Dow Jones Industrial 30 | DIA | -6.66% | -3.49% | -45.2% | -0.33% |
German DAX 40 | DAX | -6.23% | -8.46% | -71.7% | -18.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | -8.43% | -5.33% | -46.2% | 0.01% |
Hongkong Hang Seng | HSI | -9.42% | -13.4% | -53.8% | -6.30% |
India NIFTY 50 | INDA | -1.33% | 1.66% | -45.9% | 7.59% |
Brasil Bovespa | EWZ | -7.30% | -10.7% | -54.1% | 15.7% |
ACRS vs. Sectors ACRS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -6.89% | -6.91% | -52.5% | -14.2% |
Consumer Discretionary | XLY | -6.63% | -7.73% | -44.5% | -6.89% |
Consumer Staples | XLP | -5.39% | -0.09% | -52.4% | -1.74% |
Energy | XLE | -6.07% | -0.26% | -38.9% | 16.8% |
Financial | XLF | -7.35% | -7.02% | -52.5% | -15.1% |
Health Care | XLV | -3.24% | 5.63% | -40.5% | 11.4% |
Industrial | XLI | -7.94% | -10.3% | -46.9% | -3.61% |
Materials | XLB | -6.05% | -7.06% | -40.6% | 12.6% |
Real Estate | XLRE | -4.93% | -5.04% | -46.2% | -8.07% |
Technology | XLK | -7.33% | -14.7% | -42.6% | 0.28% |
Utilities | XLU | -6.30% | -3.09% | -53.1% | -10.1% |
Aerospace & Defense | XAR | -8.23% | -14.7% | -56.9% | -20.0% |
Biotech | XBI | 0.34% | -5.31% | -25.3% | 19.7% |
Homebuilder | XHB | -6.72% | -4.98% | -32.3% | 14.9% |
Retail | XRT | -8.15% | -8.15% | -41.2% | 8.86% |